1110034A24Rik Activators encompass a diverse array of chemical compounds that serve to indirectly augment the protein's functional activity through various intracellular signaling pathways. Compounds such as Forskolin, Rolipram, and IBMX work by increasing intracellular levels of cAMP, a secondary messenger that activates PKA. Once activated, PKA can phosphorylate various substrates, potentially enhancing the activity of 1110034A24Rik by promoting its involvement in cAMP-dependent signaling. Similarly, PMA, acting as a PKC activator, can initiate signaling cascades that result in the phosphorylation of proteins that may increase the functional engagement1110034A24Rik Activators encompass a diverse array of chemical compounds that serve to indirectly augment the protein's functional activity through various intracellular signaling pathways.
Compounds such as Forskolin, Rolipram, and IBMX work by increasing intracellular levels of cAMP, a secondary messenger that activates PKA. Once activated, PKA can phosphorylate various substrates, potentially enhancing the activity of 1110034A24Rik by promoting its involvement in cAMP-dependent signaling. Similarly, PMA, acting as a PKC activator, can initiate signaling cascades that result in the phosphorylation of proteins that may increase the functional engagement of 1110034A24Rik with PKC-regulated pathways. Sildenafil and SNAP 7977 act through the modulation of cGMP levels, leading to PKG activation, which may also enhance the functional activity of 1110034A24Rik via cGMP-dependent signaling. In parallel, calcium ionophores like A23187 and Ionomycin elevate intracellular calcium concentrations, possibly enhancing the activity of 1110034A24Rik through calcium-dependent kinases and their associated signaling pathways. Additionally, the polyphenol Epigallocatechin gallate, by inhibiting various protein kinases, may reduce competitive phosphorylation, thereby creating a more favorable environment for 1110034A24Rik activation within those pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, which prevents cAMP breakdown, leading to an increase in PKA activity that could indirectly enhance the function of 1110034A24Rik through similar pathways as Forskolin. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, increasing cAMP and cGMP levels, which can activate PKA and PKG, potentially leading to enhanced activity of 1110034A24Rik in cAMP/PKA or cGMP/PKG regulated processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in various signaling cascades that can phosphorylate substrates, potentially enhancing the function of 1110034A24Rik in PKC-regulated pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels, which can activate calcium-dependent kinases and signaling pathways potentially enhancing the function of 1110034A24Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is another calcium ionophore that raises intracellular calcium, thereby activating calcium-dependent signaling processes that could increase the functional activity of 1110034A24Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits several protein kinases, potentially altering signaling pathways that can lead to the enhanced functional activity of 1110034A24Rik by reducing competitive phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter downstream signaling, including AKT and mTOR pathways, potentially leading to enhanced activity of 1110034A24Rik if it is part of these pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could shift the balance of cellular signaling to pathways that positively influence the functional activity of 1110034A24Rik. | ||||||